Brinter
Winston Salem
About Brinter
Brinter is a U.S.-based medtech company pioneering 3D-bioprinted, bio-synthetic implants for orthopedic soft-tissue repair. Our core technology combines proprietary biomaterials with precision multi-material bioprinting, enabling implants engineered to mimic native biomechanical properties and promote regenerative healing. With a strong clinical advisory network and R&D operations at Wake Forest Institute for Regenerative Medicine, in North Carolina. Brinter is advancing a new standard of care for tendon and ligament reconstruction ’ beginning with rotator cuff application. The company is targeting 510(k) Class II FDA clearance and commercial launch in Q1/2028.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $10.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2025)
- Website: brinter.com
- Phone: 5614025204
Industries & Categories
3D Printing, Health Care, Life Science, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/brinter-41768 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.